Presentation ESC 2024

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Presenter: Stefano Taddei

August 31, 2024

REGISTER for free or LOG IN to view this content

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Clinical Cardiology

Clinical Pharma

Hypertension

Presentation

ESC 2024

Up Next

Presentation ESC 2024

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Presenter: Ling Tao

September 02, 2024

More slides +

Presentation ESC 2024

The efficacy of low-voltage-area ablation in patients with persistent atrial fibrillation: Results from a SUPPRESS-AF trial

Presenter: Masaharu Masuda

September 02, 2024

Presentation ESC 2024

RHEIA: Randomized researcH in womEn all comers wIth Aortic stenosis

Presenter: Hélène Eltchaninoff

August 31, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.